TRAUMALAB ApS: Financial statements 2023
CVR: 30821548
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
TRAUMALAB ApS (CVR 30821548) has filed annual accounts for 2023. In 2023, the company reported a net result of DKK 49,000 compared with DKK 49,000 the year before. Equity in the 2023 report amounted to DKK 39,303. The solvency ratio was 100%.
- Profit/Loss
- DKK 49,000
- Equity
- DKK 39,303
- Total Assets
- DKK 39,303
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | - | 49 t. | 39 t. | - |
| 2022 | - | - | 49 t. | -10 t. | - |
| 2021 | - | 0 | 0 | -10 t. | - |
| 2020 | - | 0 | 0 | -10 t. | - |
| 2019 | 0 | 0 | 0 | -10 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
TRAUMALAB ApS has published its annual report for 2022. The net result was DKK 49,000.
About TRAUMALAB ApS
TRAUMALAB ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2007. The company has been dissolved on 11 May 2026. The company was registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. In 2024, the company reported a gross profit of DKK 36,700 and a net result of DKK 36,700 compared with DKK 49,000 the year before. Equity in the 2024 report amounted to DKK 76,003.